← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksVMDPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

VMD logoViemed Healthcare, Inc. (VMD) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential

Current Price
$9.21
Market reference
Price Target
—
— Upside
Target Range
— — —
Analyst Rating
Buy
1 analysts
Forward P/E19.2x
Trailing P/E24.9x
Forward PEG—
Implied Growth+30.5%
Median Target—
Analyst Spread—

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$9.21
Consensus—
High—
Low—
Model$14.37
Bear Case
$—
—
Consensus
$—
—
Bull Case
$—
—
Valuation Model TargetsConfidence: 53/100
Bear$3
Base$14
Bull$69

Analyst Ratings Distribution

Breakdown of 1 published analyst recommendations for VMD

1/1 analysts are bullish
+50
BearishBullish
Weighted analyst sentiment score based on 1 ratings
ConsensusBuy
Coverage1 Analysts
Net Score+50
Bull / Bear100% / 0%
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%
Recommendation Mix100% Buy · 0% Hold · 0% Sell
Buy (1)Hold (0)Sell (0)

VMD Price Target Analysis

Updated May 8, 2026

As of May 8, 2026, Viemed Healthcare, Inc. (VMD) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $353M.

Analyst price targets range from a low of N/A to a high of N/A.

The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, VMD trades at a trailing P/E of 24.9x and forward P/E of 19.2x. Analysts expect EPS to grow +30.5% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $14.37, with bear and bull scenarios of $3.17 and $69.16 respectively. Model confidence stands at 53/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+34.5%
Avg Forward P/E24.8x
Peers with Coverage9 / 10
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
LINC logoLINCLincoln Educational Services Corporation$1.4B$44.10$38.80-12.0%Buy63.0x15
BRT logoBRTBRT Apartments Corp.$277M$14.72$21.00+42.6%Buy—5
EHAB logoEHABEnhabit, Inc.$706M$13.78$13.53-1.8%Hold22.8x11
HCSG logoHCSGHealthcare Services Group, Inc.$1.6B$22.31$24.50+9.8%Hold20.8x15
ADUS logoADUSAddus HomeCare Corporation$1.8B$97.29$128.67+32.3%Buy14.1x15
INSP logoINSPInspire Medical Systems, Inc.$1.3B$45.57$91.33+100.4%Hold24.5x27
NVCR logoNVCRNovoCure Limited$1.9B$16.83$33.50+99.0%Buy—15
PHG logoPHGKoninklijke Philips N.V.$25.8B$27.16——Hold17.5x22
RMD logoRMDResMed Inc.$30.1B$206.96$281.29+35.9%Buy18.8x35
HOLX logoHOLXHologic, Inc.$17.0B$76.01$79.00+3.9%Hold17.2x42

Upside Potential Comparison

INSP logoINSP
+100.4%
NVCR logoNVCR
+99.0%
BRT logoBRT
+42.6%
RMD logoRMD
+35.9%
ADUS logoADUS
+32.3%
HCSG logoHCSG
+9.8%
HOLX logoHOLX
+3.9%
EHAB logoEHAB
-1.8%

See VMD's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is VMD Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare VMD vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

VMD — Frequently Asked Questions

Quick answers to the most common questions about buying VMD stock.

What is the VMD stock price target for 2026?

The consensus price target for VMD is $N/A, close to the current price of $9.21 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.

Is VMD a buy, sell, or hold?

VMD has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

Is VMD stock overvalued or undervalued?

With a forward P/E of 19.1875x, VMD trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.

How high can VMD stock go?

The most bullish Wall Street analyst has a price target of $N/A for VMD, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $69 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover VMD stock?

VMD is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the VMD stock forecast?

The 12-month VMD stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $14, with bear/bull scenarios of $3/$69.

What is VMD's fair value based on fundamentals?

Our quantitative valuation model calculates VMD's fair value at $14 (base case), with a bear case of $3 and bull case of $69. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

What is VMD's forward P/E ratio?

VMD trades at a forward P/E ratio of 19.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 24.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy VMD stock?

VMD appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do VMD price targets vary so much?

VMD analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $3-$69 range provides an independent fundamental perspective.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.